# SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

Study · id `cardio:ct-nct04722250` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04722250](<https://clinicaltrials.gov/study/NCT04722250>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04722250

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1103 participants.

## Technical summary

Registry record NCT04722250. Randomized; no masking; primary purpose treatment. Start 2021-04-02 (actual); primary completion 2023-11-10 (actual). Results posted on 2025-03-20.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1103 participants (enrolled count; ClinicalTrials.gov record NCT04722250, source copy `cardio:ctgov-nct04722250-2026-06-02`, retrieved 2026-10-26)
- Started: 2021-04-02 (actual) (ClinicalTrials.gov record NCT04722250, source copy `cardio:ctgov-nct04722250-2026-06-02`, retrieved 2026-10-26)
- Primary completion: 2023-11-10 (actual) (ClinicalTrials.gov record NCT04722250, source copy `cardio:ctgov-nct04722250-2026-06-02`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT04722250, source copy `cardio:ctgov-nct04722250-2026-06-02`, retrieved 2026-10-26)
- Results first posted: 2025-03-20 (ClinicalTrials.gov record NCT04722250, source copy `cardio:ctgov-nct04722250-2026-06-02`, retrieved 2026-10-26)
- Countries: United States; Canada; Denmark; Finland; France; Germany; Israel; Italy; Netherlands; Portugal; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT04722250, source copy `cardio:ctgov-nct04722250-2026-06-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04722250-2026-06-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
- Acronym: SMART
- Condition: Symptomatic Aortic Stenosis
- Condition: Aortic Valve Stenosis
- Condition: Aortic Valve Replacement
- Intervention (Device): Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV Systems
- Intervention (Device): Edwards SAPIEN 3 or SAPIEN 3 Ultra THV Systems
- Lead sponsor: Medtronic Cardiovascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus (`cardio:pubmed-38587261`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial (`cardio:pubmed-39382856`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b6aa00dfb41dd52590f347ef2d8fdeaed6710f7888614174b58fa87c2e8c5b14
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
